Age: 87.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain, Pruritus, Vaccination site pain
Clinical narrative: whole body was itching; caused her arm to start hurting; upset stomach; nausea; muscle cramping; major lethargy; generalized pains; mild anaphylactic shock; This is a spontaneous report from a contactable consumer (patient). An 87-year-old female patient received BNT162B2 (Pfizer-BioNTech COVID-19 vaccine), via an unspecified route of administration, administered in the left arm on 07Sep2021 at 10:00 (Lot Number: FD8448, Expiration Date not reported) as dose 3, single for COVID-19 immunization. Medical history included low thyroid output from 2021 and ongoing, ongoing high cholesterol from an unknown date, ongoing mild depression from an unknown date, urinary incontinence on an unknown date in 2021, anaphylactic reaction to sulfa on an unknown date, 50 years ago and her throat and breathing became impaired and was allergic to mosquito bites on an unknown date. Concomitant medications included levothyroxine (manufacturer unknown) taken for low thyroid output from 2021 and ongoing; atorvastatin (manufacturer unknown) taken for high cholesterol from an unspecified start date and ongoing; escitalopram oxalate (LEXAPRO) taken for mild depression from an unspecified start date and ongoing; bupropion hydrochloride (manufacturer unknown) taken for mild depression from 2020 and ongoing; ascorbic acid, beta-carotene, biotin, calcium, chloride, chromium, copper, folic acid, iodine, iron, magnesium, manganese, molybdenum, nickel, nicotinic acid, pantothenic acid, phosphorus, potassium, pyridoxine hydrochloride, riboflavin, selenium, silicon, thiamine, vanadium, vitamin b12 nos, vitamin d nos, vitamin e nos, vitamin k nos, xantofyl, zinc (CENTRUM SILVER WOMEN 50+) taken to improve her bad diet from an unspecified start date and ongoing; calcium, colecalciferol (CALCIUM WITH D3) taken to improve her bad diet from an unspecified start date and ongoing; tolterodine l-tartrate (DETROL) taken for urinary incontinence from 2021 and ongoing. The patient previously received BNT162B2 on 25Feb2021 (lot number: EN6203, expiry date: Jun2021) for the first dose (at 86-years-old) and 18Mar2021 (lot number: EN6204, expiry date: unknown) for the second dose (at 87-years-old) both in the left arm for COVID-19 immunization. The patient did not receive prior vaccinations within 4 weeks prior to the administration date of the vaccine. The patient reported that she did not have a reaction to the first two doses. The third dose caused her arm to start hurting an hour after the shot on 07Sep2021 but has improved but was still painful, but it was not red, no rash around the shot site but was painful. The patient also had an upset stomach, major nausea, major lethargy, major muscle cramping and generalized pains on 07Sep2021 that are much less improved and is ongoing. The patient also reported that her whole body was itching on 08Sep2021, 14 hrs after the vaccination  and as treatment she is took 50 mg of diphenhydramine that are making her woozy and sleepy, but they are working as the itching had already improved since taking the medicine. The patient read that she might have a mild anaphylactic shock. She asked how to deal with this reaction.  She was still dealing with this 3 days later. She wanted to know what the severe reactions have been to the Pfizer covid 19 vaccine, what are the ages and what percentage of people that were getting severe reactions from the vaccine. The patient asked if the 3rd dose is more severe. The patient asked if there was any idea of why very few people are getting very few severe reactions.  The outcome of the event mild anaphylactic shock was unknown while the outcome of the rest of the events was recovering.   No follow-up attempts are possible. No further information is expected.